Posterior fossa syndrome in a patient with an ornithine transcarbamylase deficiency

S. C M Nedermeijer*, J. Van Den Hout, C. Geleijns, H. De Klerk, C. E. Catsman-Berrevoets

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The posterior fossa syndrome (PFS) is a well-known clinical entity and mainly occurs in children. Ornithine transcarbamylase deficiency (OTC) is the most common urea cycle disorder, which occurs in an estimated 1 per 50.000 live births in Japan. Symptoms are mostly due to hyperammonemia and include nausea, vomiting, lethargia and even convulsions and coma. Common neurological symptoms at presentation of a hyperammonemia are a decreased level of consciousness, abnormal motor function or seizures. In this case we describe a girl with late onset OCT deficiency presenting with transient mutism and subsequent dysarthria, ataxia and behavioural changes. This is an exceptional report of a not yet described neurologic syndrome in OTC. Synopsis: Neurologic symptoms in ornithine transcarbamylase deficiency do not only occur during an episode of hyperammonemia and may present as a transient neurologic symptoms compatible with the posterior fossa syndrome.

Original languageEnglish
Pages (from-to)364-366
Number of pages3
JournalEuropean Journal of Paediatric Neurology
Volume19
Issue number3
DOIs
Publication statusPublished - 1 May 2015

Keywords

  • Ornithine transcarbamylase deficiency
  • OTC
  • PFS
  • Posterior fossa syndrome

Fingerprint

Dive into the research topics of 'Posterior fossa syndrome in a patient with an ornithine transcarbamylase deficiency'. Together they form a unique fingerprint.

Cite this